Evidence map›Paper›PMID 34130548›Full record

ReviewPerspectives in public health2023

Addressing high cervical cancer rates in the Rio Grande Valley along the Texas-Mexico border: a community-based initiative focused on education, patient navigation, and medical provider training/telementoring.

M P Salcedo, R Gowen, A M Rodriguez, S Fisher-Hoch, M Daheri, L Guerra, P A Toscano, M Gasca, J Morales, F E Reyna-Rodriguez and 14 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Perspectives in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

M P SalcedoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-6375-0736
R GowenSu Clínica, Brownsville, TX, USA.
A M RodriguezThe University of Texas Medical Branch, Galveston, TX, USA.
S Fisher-HochSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
M DaheriSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
L GuerraSu Clínica, Brownsville, TX, USA.
P A ToscanoUTHealth McGovern Medical School, Houston, TX, USA.
M GascaSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
J MoralesSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
F E Reyna-RodriguezUTHealth McGovern Medical School, Houston, TX, USA.
B CavazosSu Clínica, Brownsville, TX, USA.
E MarinSu Clínica, Brownsville, TX, USA.
C PerezSu Clínica, Brownsville, TX, USA.
M GuerraThe University of Texas Medical Branch, Galveston, TX, USA.
A MilbourneThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
M L VaronThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-8960-8017
B ReiningerSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
M E FernandezSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
T OgburnThe University of Texas Rio Grande Valley Medical School, Edinburg, TX, USA.
P E CastleNational Cancer Institute, National Institutes of Health, Rockville, MD, USA.
J McCormickSchool of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
E BakerThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
E HawkThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
K M SchmelerDepartment of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Unit 1362, 1515 Holcombe Boulevard, Houston, TX 77030, USA.ORCID 0000-0002-9670-4189

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
NCATS NIH HHS UL1 TR003167NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

aimsCervical cancer incidence and mortality rates are approximately 55% higher in the Rio Grande Valley (RGV) along the Texas-Mexico border compared with the average rates in the US. Our aim was to improve cervical cancer prevention efforts in the RGV through a comprehensive multilevel intervention initiative focused on community education, patient navigation, and training of local providers.

methodsWe initiated a program in the RGV which consisted of (1) community education, (2) patient navigation, and (3) a training/mentoring program for local medical providers including hands-on training courses coupled with telementoring using

resultsFrom November 2014 to October 2018, 14,846 women underwent cervical cancer screening. A total of 2030 (13.7%) women underwent colposcopy for abnormal results (179% increase over baseline) and 453 women underwent loop electrosurgical excision procedures (LEEPs) for treatment of cervical dysplasia. Invasive cancer was diagnosed in 39 women who were navigated to a gynecologic oncologist for treatment. Seven local medical providers were trained to perform colposcopy and/or LEEP. Project ECHO telementoring videoconferences were held every 2 weeks for a total 101 sessions with an average of 22 participants per session and a total of 180 patient cases presented and discussed.

conclusionsOur program led to a large number of women undergoing diagnosis and treatment of cervical dysplasia in the RGV. If sustained, we anticipate these efforts will decrease cervical cancer rates in the region. The program is currently being expanded to additional underserved areas of Texas and globally to low- and middle-income countries.

Indexed as

Patient NavigationUterine Cervical DysplasiaUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansMexicoTexascervical cancerhuman papillomavirus (HPV)preventionscreeningtelementoring

Identifiers

PMID34130548
PMCPMC13170690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.